D dimer News and Research

RSS

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.

27 Aug 2018

WVU professor develops new, faster method for ruling out DVT in patients

Getting tested for deep vein thrombosis, or DVT, can disrupt a patient's whole day. Typically, one of the first methods a clinician uses to diagnose the condition is an ultrasound in order to see the blood vessels in a patient's legs and assess blood flow.

22 Aug 2018

Researchers develop new model for predicting cancer-associated venous thrombosis

In collaboration with international partners, a study group from the Medical University of Vienna has developed a new model for predicting cancer-associated venous thrombosis/pulmonary embolism.

11 Jul 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

Patients with high-risk clinical features have greater risk for acute aortic dissection

Patients with one or more high-risk clinical features (tearing pain, hypotension, pulse deficit, neurologic deficit, new murmur) should be considered high risk for acute aortic dissection.

10 Apr 2018

Case report of a 21 year old woman sweating blood

She had a rare condition called hematohidrosis where she was sweating blood and her tears too contained blood. The dermatologists published the report of her rare case while protecting her identity, this week in the Canadian Medical Association Journal.

24 Oct 2017

IDT introduces novel rhAmp technology for accurate, cost-effective SNP analysis

Reflecting its mission to provide innovative solutions to the genomics community, Integrated DNA Technologies introduces its unique rhAmp™ SNP Genotyping System, enabling researchers to make accurate and confident SNP calls both quickly and cost-effectively.

19 Jun 2017

New strategy in antimicrobial peptides holds promise for combating multi-drug resistant bacteria

In an article published recently in Plos One, researchers from INRS-Institut Armand-Frappier Research Centre reported a strategy that could lead to the discovery of new cationic antimicrobial peptides (CAMPs) with greatly enhanced antimicrobial properties.

5 Apr 2017

ISS crew members grow crystals for drug development

Crew members aboard the International Space Station will begin conducting research this week to improve the way we grow crystals on Earth. The information gained from the experiments could speed up the process for drug development, benefiting humans around the world.

31 Mar 2017

New Danish research provides structural knowledge of DNA repair complex

New Danish research provides mechanistic insight into how DNA is monitored and repaired if damage occurs. The results may eventually help to improve the treatment of certain types of cancer, as the DNA repair complex provides a mechanism for cancer cells to resist chemotherapy.

21 Mar 2017

Scientists generate new insights into intricate molecular underpinnings of ubiquitin signaling

Scientists at the University of Würzburg have generated new insights into the intricate molecular underpinnings of ubiquitin signaling. Their results may provide new avenues for cancer therapy.

13 Feb 2017

Scientists define working mechanism of promising anti-cancer molecules

An international team of scientists, including MIPT researchers, has defined the way their promising anti-cancer molecules work.

25 Jan 2017

ACA financial penalties lead to reductions in hospital readmission rates for common conditions

Financial penalties levied under the Affordable Care Act's Hospital Readmissions Reduction Program lead to the poorest performing hospitals to achieve the greatest reductions in readmission rates for common conditions.

27 Dec 2016

Obstructive sleep apnea can increase risk for PE recurrence

Pulmonary embolism (PE) is a major risk for patients suffering from venous thromboembolism (VTE) and can often be fatal.

7 Dec 2016

biosurfit announces CE Marking for new HbA1c test

Today, biosurfit SA, the in vitro point-of-care (PoC) diagnostics company, announces CE Marking (Conformité Européenne) for its HbA1c (Haemoglobin A1c) test, the third in a series of tests available on its spinit point-of-care instrument.

1 Dec 2016

Novel bifunctional dimers show promise in preventing Parkinson's disease

A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.

30 Sep 2016

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD).

22 Sep 2016

Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Patients with suspected pulmonary embolism (PE) often undergo computed tomography pulmonary angiography (CTPA) to confirm or exclude the diagnosis.

31 Aug 2016

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

A clinical decision rule (CDR) that can be applied to women after a first, unprovoked venous thromboembolism (VTE) was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016.

30 Aug 2016